Eupraxia Pharmaceuticals holds annual shareholder meeting

• Eupraxia Pharmaceuticals held its annual general meeting on June 18, 2026.
• Shareholders adopted a resolution to appoint seven directors to serve until the next annual meeting or until successors are chosen.
• A separate resolution to reappoint KPMG as auditor for the ensuing year was carried.
• Shareholders also authorized the board to set the auditor’s remuneration; the authorization was adopted.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eupraxia Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606191602PRIMZONEFULLFEED9749911) on June 19, 2026, and is solely responsible for the information contained therein.